14-day Premium Trial Subscription Sign Up For FreeGet Free

$519.49 (-7.27%)

Volume: 1M

Closed: Dec 03, 2021

Hollow Logo Score: -2.056

DexCom Stock Forecast

$519.49 (-7.27%)

Volume: 1M

Closed: Dec 03, 2021

Score Hollow Logo -2.056
Which way will DXCM go? Request
Key Stats
P/E Ratio 95.13
Beta 1.15
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The DexCom stock currently holds an RSI14 at 16 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

DexCom stock price took a fall of -7.27% on Friday
(Updated on Dec 03, 2021)


Sell candidate since 2021-11-26 Loss -12.24%

The DexCom stock price fell by -7.27% on the last day (Friday, 3rd Dec 2021) from $560.22 to $519.49. During the day the stock fluctuated 9.05% from a day low at $514.53 to a day high of $561.07. The price has fallen in 8 of the last 10 days and is down by -19.88% for this period. Volume has increased on the last day by 608 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $739.45 million.

Given the current short-term trend, the stock is expected to rise 12.97% during the next 3 months and, with a 90% probability hold a price between $586.87 and $751.03 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The DexCom stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $564.60 and $598.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, November 17, 2021, and so far it has fallen -20.23%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The stock had a Golden Star Signal on Thursday, January 21, 2021 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Thursday, January 21, 2021 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $46.54 between high and low, or 9.05%. For the last week, the stock has had a daily average volatility of 5.01%.

DexCom is oversold on RSI14 (16). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is DexCom stock A Buy?

The DexCom stock holds several negative signals and despite the positive trend, we believe DexCom will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.056

Predicted Opening Price for DexCom of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$531.70 $519.49 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 01, 2021 "Raymond James" gave "$515.00 - $618.00" rating for DXCM. The price target was set to $623.21+9.3%.

Volatility and Risk
Daily Average Volatility: 5.01 %
Overall Risk: Very High High Medium Low Very Low
Volatility
5.01 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $562.59
Price: $519.49
No Support Found

DXCM Insider Trading Show all Trades

INSIDER POWER

0.0436

Last 100 transactions
Buy: 2 498 | Sell: 57 293 (Shares)
Date Action Amount Person Type
Dec 01, 2021 Sell 41 Foletta Mark G Common Stock
Dec 01, 2021 Sell 2 Foletta Mark G Common Stock
Dec 01, 2021 Sell 87 Foletta Mark G Common Stock
Dec 01, 2021 Sell 65 Foletta Mark G Common Stock
Dec 01, 2021 Sell 116 Foletta Mark G Common Stock
Show all Insider Trades
INSIDER POWER

0.0436

Last 100 transactions
Buy: 2 498 | Sell: 57 293 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 578.24 11.31 %
560.46 7.89 %
549.47 5.77 %
Current price: 519.49
Support 513.92 -1.07 %
502.93 -3.19 %
485.16 -6.61 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 623.21 19.97 %
571.01 9.92 %
562.59 8.30 %
Current price 519.49
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes DexCom G4 PLATINUM system for continuous use by ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT